(June 12, 2009 - Insidermedicine) From the UK - According to the STOPPIT study published in the Lancet, hormone treatment does not appear to lower the chances of premature labor. In a study of 500 women with twin pregnancy, half of whom received intravaginal progesterone gel, and the other placebo, premature labor, considered birth prior to 34 weeks, was noted in approximately one fifth of women.

From New Orleans - According to research presented to the American Diabetes Association, weight-loss drugs may hold promise for the treatment of diabetes. In a study of the diet drugs Lorcaserin, Qnexa, and Contrave , all three were associated with improvements in risk factors other than obesity, including blood glucose, blood pressure and triglycerides. Presently, none of the drugs are FDA approved.

And finally, from Palo Alto - According to research published in the Archives of Neurology, breast-feeding may be beneficial for women with multiple sclerosis. In a study of nearly 30 women with MS, those who breast fed exclusively for over 2 months had over a 50% reduction in relapse of their disease. The findings call into question the benefit of foregoing breastfeeding to start MS therapies.